Seretra – 80

DSCN446611 copy

Composition

Each tablet contains:

Seratrodast……….. 80 mg

Description

Seratrodast is an orally active quinone derivative and a potent TXA2 receptor antagonist used in the prophylactic management of asthma.

Indications

Seretra is indicated in prophylactic management of mild to moderate asthma.

Contraindications

  • Hypersensitivity to Seretra or any of the ingredients
  • Patients with hepatic failure

Warnings & Precautions

Seretra may lead to an elevation in the levels of the hepatic enzymes. Therefore, it has to be administered with caution in patients with hepatic impairment.

Manufactured by
zuventus logo
(A JV Company of Emcure Pharmaceuticals Ltd.)
5119, ‘D’ Wing, Oberoi Garden Estate,
Chandivali, Mumbai 400 072, India

PLEASE SEE FULL PRESCRIBING INFORMATION

Advertisements